Rare diseases
Investigational molecules
Locations
Carrer Pedro I Pons 1, 08195 Sant Cugat Del Valles, Spain
Hospital Universitari General De Catalunya in Sant Cugat Del Valles, Spain specialises in clinical trials of conditions such as Dementia Alzheimer's type, Parkinson's disease, Breast cancer, Hormone receptor positive HER2 negative breast cancer, and other specialisations. This site conducts important research.
The medical center is at the forefront of breast cancer research, focusing on innovative treatments for ER-positive, HER2-negative and triple-negative breast cancer. The center's studies explore the efficacy of novel drug combinations, aiming to improve progression-free survival rates and manage treatment-related side effects.
Through these studies, the center contributes significantly to the development of personalized cancer therapies, enhancing patient outcomes and quality of life.
Specializing in Alzheimer's disease research, the center conducts trials on innovative therapies targeting early-stage cognitive decline. These studies aim to slow disease progression and improve cognitive function, utilizing advanced biomarkers and novel therapeutic agents.
The center's work in this field is pivotal in advancing our understanding of neurodegenerative diseases and developing effective interventions.
The center is renowned for its research in Parkinson's disease, focusing on the safety and efficacy of new treatments aimed at reducing motor fluctuations and improving patient quality of life. These studies explore both early-stage interventions and long-term management strategies.
By advancing therapeutic options, the center plays a crucial role in enhancing the lives of those affected by Parkinson's disease.
Focusing on age-related macular degeneration and diabetic retinopathy, the center's research aims to develop treatments that preserve vision and improve patient outcomes. These studies evaluate the efficacy of novel drug formulations and delivery systems.
The center's contributions are vital in the quest to combat vision loss and enhance the quality of life for patients with these conditions.
In the realm of infertility treatment, the center is pioneering research on innovative hormonal therapies and their impact on reproductive outcomes. These studies aim to optimize treatment protocols and improve success rates for patients undergoing assisted reproductive technologies.
Through its research, the center is enhancing the understanding and management of reproductive health challenges.
More sites in Sant Cugat Del VallesSpain
Clinical trials currently enrolling participants at this site.
Phase 1/2 Study of ter-2013-01, imlunestrant, and fulvestrant in patients with solid tumors with AKT/PI3K/PTEN pathway alterations
SpainEfficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration
SpainEvaluation of zongertinib, fulvestrant and goserelin acetate in patients with HR‑positive HER2‑negative advanced breast cancer
SpainSpainFWY003 in Geographic Atrophy Secondary to Age-Related Macular Degeneration in Patients
SpainA study to evaluate the effectiveness and safety of efaglomograstim alfa in patients with low blood platelet counts caused by chemotherapy
SpainA study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy
SpainStudy of elacestrant and ribociclib compared to standard treatment for patients with high-risk ER+/HER2- early breast cancer
SpainA study comparing prasinezumab with placebo for people with early-stage Parkinson's disease
SpainA Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer
SpainStudy of Semaglutide on Embryo Quality in Overweight and Obese Women Undergoing In Vitro Fertilization for Infertility
SpainStudy of xanomeline tartrate and trospium chloride combination for cognitive impairment in people with mild to moderate Alzheimer's disease
SpainMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
